We often hear talk about this topic: many companies, particularly larger corporations, seem to have trouble connecting with their target audience. This can be attributed to a variety of factors, but one recurring theme remains. In many industries, there is a large disconnect and gap between the senior executives and the end consumer.
While this may not seem like the end of the world — after all, the company isn’t selling or promoting its executive team — this perception can still have a bearing effect on the reputation of the company among consumers.
Consider this. The CEO of a pharmaceutical company has been embroiled in controversy over recent litigation surrounding the promotion of opioids to doctors. The CEO repeatedly goes on public record to renounce the shady practices of alleged bribery by representatives that push doctors to prescribe medications and painkillers that can be highly addictive.
However, while the CEO is on the podium committing to stopping these practices, the pharmaceutical reps on the ground continue to act in the exact opposite manner. They do whatever it takes to make the sale, even at the risk of the health of thousands of patients.
This conflicting behavior, unfortunately, reflects the most on the executives of the company. The fact that the CEO either refuses to acknowledge or does not know about the alleged malpractice shows a distinct lack of touch and connection to the issue. In turn, this causes consumers to lose trust in the company — an uphill battle to begin with for big corporations in industries such as big pharma.
Bridging the Gap: How Higher Level Executives Can Reach the Average Consumer

We often hear talk about this topic: many companies, particularly larger corporations, seem to have trouble connecting with their target audience. This can be attributed to a variety of factors, but one recurring theme remains. In many industries, there is a large disconnect and gap between the senior executives and the end consumer.
While this may not seem like the end of the world — after all, the company isn’t selling or promoting its executive team — this perception can still have a bearing effect on the reputation of the company among consumers.
Consider this. The CEO of a pharmaceutical company has been embroiled in controversy over recent litigation surrounding the promotion of opioids to doctors. The CEO repeatedly goes on public record to renounce the shady practices of alleged bribery by representatives that push doctors to prescribe medications and painkillers that can be highly addictive.
However, while the CEO is on the podium committing to stopping these practices, the pharmaceutical reps on the ground continue to act in the exact opposite manner. They do whatever it takes to make the sale, even at the risk of the health of thousands of patients.
This conflicting behavior, unfortunately, reflects the most on the executives of the company. The fact that the CEO either refuses to acknowledge or does not know about the alleged malpractice shows a distinct lack of touch and connection to the issue. In turn, this causes consumers to lose trust in the company — an uphill battle to begin with for big corporations in industries such as big pharma.